SCHEMBL7744086

SCHEMBL7744086

O=C(Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1ccc(C(F)(F)F)cc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.51
FLT1 P17948 1/20 0.51
FLT4 P35916 1/20 0.51
HDAC2 Q92769 2/20 0.48
ADCY1 Q08828 1/20 0.44
HDAC1 Q13547 2/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
CHUK O15111 1/20 0.42
TXNRD1 Q16881 1/20 0.42
NOX4 Q9NPH5 1/20 0.42
P2RX1 P51575 1/20 0.42
NTRK1 P04629 1/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2C19 P33261 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ACLY P53396 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746598 0.93 KDR (0.58) KDRFLT1FLT4HDAC2ADCY1
SCHEMBL7746616 0.90 KDR (0.65) KDRFLT1FLT4HDAC1CHUK
SCHEMBL7739023 0.89 HDAC2 (0.48) KDRFLT1FLT4HDAC2ADCY1
SCHEMBL7985537 0.88 KDR (0.53) KDRFLT1FLT4HDAC2HDAC1
SCHEMBL7744087 0.85 KDR (0.46) KDRFLT1FLT4HDAC2ADCY1
SCHEMBL7746627 0.84 KDR (0.48) KDRFLT1FLT4ALDH1A1KDM4E
SCHEMBL7744167 0.84 HDAC1 (0.53) KDRFLT1FLT4HDAC2HDAC1
SCHEMBL7744059 0.84 KDR (0.53) KDRFLT1FLT4HDAC2HDAC1
SCHEMBL4787849 0.84 ADCY1 (0.49) KDRFLT1FLT4HDAC2ADCY1
SCHEMBL7739025 0.82 FLT1 (0.42) KDRFLT1FLT4HDAC2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed